Literature DB >> 25986596

Transcutaneous Peptide Immunotherapy of Japanese Cedar Pollinosis Using Solid-in-Oil Nanodispersion Technology.

Momoko Kitaoka1, Yoko Shin1, Noriho Kamiya1,2, Yoshinori Kawabe3, Masamichi Kamihira3, Masahiro Goto4,5.   

Abstract

Peptide immunotherapy is an attractive approach to relieve allergic symptoms such as rhinitis and asthma. Treatment of Japanese cedar pollinosis (Cryptomeria japonica; Cj), from which over one quarter of Japanese population suffer, is becoming a great concern. Recently, oral feeding of a peptide (7crp) consisting of seven immunodominant human T cell epitopes derived from two enzymes present in Cj pollen was demonstrated to have a benefit in treating Cj pollinosis. In this work, we aimed to apply a novel transcutaneous administration system as a simple and easy peptide delivery for an immunotherapy using a T cell epitope peptide. A modified 7crp peptide (7crpR) which contained triarginine linkers between each epitopes was designed to increase water solubility and was encapsulated in a unique solid-in-oil (S/O) nanodispersion. The S/O nanodispersion consists of a nano-sized peptide-surfactant complex dispersed in an oil vehicle. The S/O nanopartilces having an average diameter of 230 nm facilitated the permeation of the peptide 7crpR into the skin and suppressed serum total IgE and antigen-specific IgE levels in a Cj pollinosis mouse model. Transcutaneous administration of the T cell epitope peptide using the S/O nanodispersion system has potential for future simple and easy immunotherapy of Cj pollinosis.

Entities:  

Keywords:  epitope peptide; immunotherapy; pollinosis; solid-in-oil nanodispersion; transdermal drug delivery

Mesh:

Substances:

Year:  2015        PMID: 25986596      PMCID: PMC4666251          DOI: 10.1208/s12249-015-0333-x

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  22 in total

1.  Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens.

Authors:  K Hirahara; T Tatsuta; T Takatori; M Ohtsuki; H Kirinaka; J Kawaguchi; N Serizawa; Y Taniguchi; S Saito; M Sakaguchi; S Inouye; A Shiraishi
Journal:  J Allergy Clin Immunol       Date:  2001-07       Impact factor: 10.793

2.  Transdermal immunization using solid-in-oil nanodispersion with CpG oligodeoxynucleotide adjuvants.

Authors:  Momoko Kitaoka; Ayaka Naritomi; Yuya Hirakawa; Noriho Kamiya; Masahiro Goto
Journal:  Pharm Res       Date:  2014-11-01       Impact factor: 4.200

3.  Transcutaneous immunization by a solid-in-oil nanodispersion.

Authors:  Yoshiro Tahara; Kenichi Namatsu; Noriho Kamiya; Masayori Hagimori; Seitaro Kamiya; Masayuki Arakawa; Masahiro Goto
Journal:  Chem Commun (Camb)       Date:  2010-10-28       Impact factor: 6.222

4.  Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

Authors:  Christian Möller; Sten Dreborg; Hosne A Ferdousi; Susanne Halken; Arne Høst; Lars Jacobsen; Antti Koivikko; Dieter Y Koller; Bodo Niggemann; Lene A Norberg; Radvan Urbanek; Erkka Valovirta; Ulrich Wahn
Journal:  J Allergy Clin Immunol       Date:  2002-02       Impact factor: 10.793

5.  Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1.

Authors:  L Bauer; B Bohle; B Jahn-Schmid; U Wiedermann; A Daser; H Renz; D Kraft; C Ebner
Journal:  Clin Exp Immunol       Date:  1997-03       Impact factor: 4.330

6.  A new murine model of allergic rhinitis by repeated intranasal Cry j 1 challenge.

Authors:  Masako Tsunematsu; Taketo Yamaji; Daisuke Kozutsumi; Rika Murakami; Hiroichi Nagai; Kohsuke Kino
Journal:  Biomed Res       Date:  2008-06       Impact factor: 1.203

7.  Analysis of conformational and sequential IgE epitopes on the major allergen Cry j 2 of Japanese cedar (Cryptomeria japonica) pollen in humans by using monoclonal antibodies for Cry j 2.

Authors:  Kazuki Miyaji; Terumi Yurimoto; Akemi Saito; Hiroshi Yasueda; Yukari Takase; Hidekatsu Shimakura; Noriaki Okamoto; Akio Kiuchi; Saburo Saito; Masahiro Sakaguchi
Journal:  J Clin Immunol       Date:  2013-03-16       Impact factor: 8.317

8.  Sensitivity to two major allergens (Cry j I and Cry j II) in patients with Japanese cedar (Cryptomeria japonica) pollinosis.

Authors:  M Hashimoto; H Nigi; M Sakaguchi; S Inouye; K Imaoka; H Miyazawa; Y Taniguchi; M Kurimoto; H Yasueda; T Ogawa
Journal:  Clin Exp Allergy       Date:  1995-09       Impact factor: 5.018

Review 9.  Present situation of cedar pollinosis in Japan and its immune responses.

Authors:  Yoshitaka Okamoto; Shigetoshi Horiguchi; Heizaburo Yamamoto; Syuji Yonekura; Toyoyuki Hanazawa
Journal:  Allergol Int       Date:  2009-03-25       Impact factor: 5.836

10.  Oral immunotherapy for pollen allergy using T-cell epitope-containing egg white derived from genetically manipulated chickens.

Authors:  Yoshinori Kawabe; Yuuki Hayashida; Kensaku Numata; Shota Harada; Yoshifumi Hayashida; Akira Ito; Masamichi Kamihira
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

View more
  5 in total

Review 1.  Novel strategies in immunotherapy for allergic diseases.

Authors:  Mohana Rajakulendran; Elizabeth Huiwen Tham; Jian Yi Soh; H P Van Bever
Journal:  Asia Pac Allergy       Date:  2018-04-09

2.  Transcutaneous pollinosis immunotherapy using a solid-in-oil nanodispersion system carrying T cell epitope peptide and R848.

Authors:  Momoko Kitaoka; Ayaka Naritomi; Yoshinori Kawabe; Masamichi Kamihira; Noriho Kamiya; Masahiro Goto
Journal:  Bioeng Transl Med       Date:  2017-02-03

3.  Preparation and Characterization of a Glycyrrhizic Acid-Based Drug Delivery System for Allergen-Specific Immunotherapy.

Authors:  Ekaterina Pashkina; Veronika Evseenko; Natalya Dumchenko; Maxim Zelikman; Alina Aktanova; Maria Bykova; Mikhail Khvostov; Aleksandr Dushkin; Vladimir Kozlov
Journal:  Nanomaterials (Basel)       Date:  2021-12-31       Impact factor: 5.076

Review 4.  Solid-in-oil nanodispersions for transdermal drug delivery systems.

Authors:  Momoko Kitaoka; Rie Wakabayashi; Noriho Kamiya; Masahiro Goto
Journal:  Biotechnol J       Date:  2016-08-16       Impact factor: 4.677

5.  Transcutaneous Delivery of Immunomodulating Pollen Extract-Galactomannan Conjugate by Solid-in-Oil Nanodispersions for Pollinosis Immunotherapy.

Authors:  Qingliang Kong; Kouki Higasijima; Rie Wakabayashi; Yoshiro Tahara; Momoko Kitaoka; Hiroki Obayashi; Yanting Hou; Noriho Kamiya; Masahiro Goto
Journal:  Pharmaceutics       Date:  2019-10-30       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.